Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Mivebresib |
Trade Name | |
Synonyms | ABBV-075 |
Drug Descriptions |
Mivebresib (ABBV-075) is a bromodomain (BET) inhibitor, which may disrupt transcriptional regulation and lead to apaotosis of tumor cells (PMID: 28416490, PMID: 31420359). |
DrugClasses | BET Inhibitor (Pan) 32 |
CAS Registry Number | 1445993-26-9 |
NCIT ID | C121829 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Azacitidine + Mivebresib | Azacitidine Mivebresib | 0 | 0 |
Bortezomib + Mivebresib | Bortezomib Mivebresib | 0 | 0 |
Mivebresib | Mivebresib | 0 | 2 |
Mivebresib + Navitoclax | Mivebresib Navitoclax | 0 | 1 |
Mivebresib + Obatoclax | Mivebresib Obatoclax | 0 | 0 |
Mivebresib + Ruxolitinib | Mivebresib Ruxolitinib | 0 | 1 |
Mivebresib + Venetoclax | Mivebresib Venetoclax | 0 | 0 |